Editorial: The role of normal blood lipid levels in metabolic and endocrine diseases - Summary - MDSpire

Editorial: The role of normal blood lipid levels in metabolic and endocrine diseases

  • By

  • Rubing Guo

  • Wei Zhao

  • July 3, 2026

  • 0 min

Share

Objective:

To highlight the significance of maintaining normal blood lipid levels in the context of metabolic and endocrine diseases and to advocate for a shift from rigid threshold-based lipid management to a more nuanced understanding of lipid fluctuations.

Approach:
  • Introduction: Discusses the global health burden of metabolic and endocrine diseases and the dual role of blood lipids in human physiology.
  • Early insulin resistance and diabetes risk: Highlights studies showing that the triglyceride-glucose (TyG) index can predict diabetes risk even in individuals with normal lipid levels.
  • Remnant cholesterol: Explores the role of remnant cholesterol as a predictor of glycemic recovery and its associations with insulin resistance.
  • Composite lipid indices: Describes the advantages of composite lipid indices over traditional markers in predicting metabolic disturbances.
  • Trace elements and lipoprotein interactions: Examines how whole-blood copper concentration interacts with apolipoprotein B levels in relation to glycemic control.
Key Findings:
  • The TyG index is a strong predictor of diabetes risk, even within normal lipid ranges.
  • Incremental increases in LDL-C within the normal range are associated with higher diabetes risk.
  • Remnant cholesterol is a potent predictor of glycemic recovery and is linked to insulin resistance.
  • Composite lipid indices often outperform traditional lipid markers in predicting metabolic disturbances.
  • Copper levels in relation to glycemic control are modified by apolipoprotein B levels.
Interpretation:

The findings suggest that maintaining normal blood lipid levels is crucial for reducing metabolic risk, and that traditional binary classifications may overlook significant individual risk factors.

Limitations:
  • The studies referenced may have population-specific limitations and may not be generalizable to all demographics.
  • The editorial does not provide extensive data on the methodologies of the studies discussed.
Conclusion:

A paradigm shift towards continuous risk assessment of lipid levels is necessary to better understand and manage metabolic health.

Original Source(s)

Related Content